TransMedics, Inc. Closes $25.5 Million in Series D Funding
ANDOVER, Mass.--(BUSINESS WIRE)--TransMedics, Inc., an emerging medical technology company developing advanced solutions to address the unmet need for better, more effective organ transplants, announced today that it has closed a $25.5 million Series D private equity financing led by funds affiliated with and advised by Tudor Investments.